Lactobacillus on recovering of immune-damage by chemotherapy (cancer treatment)

Here, we tackle the problem linked to chemotherapy as a main remedyfor cancer, emphasizing on its severe impact on the immune system andtherefore on the urgent need for new additive biomedical products incancer treatment.The experiment was conducted using a rat model of chemotherapy (cyclophosphamide CTX), which was shown to have a depleted immune system.In this new study, we showed the complete rat microbiota, i.e. the collection of fungal and bacterial microorganisms, which resides in the rat intestinal gut flora inrelation with chemotherapy for cancer and new lactobacillus probioticpharmacology (see 16S and ITS sequences).We report about several bacterial and fungal phyla,classes, orders, families, genera and species associated withchemotherapy and immune injury.We also report about specific bacterial and fungal strains that are specifically regulated by addition of Lactobacillus (three doses) to CTX chemo.We demonstrate that a new natural pharmacological agent (3L bioproduct, 3lactobacilli) is extremely efficient in re-establishing a strong sustainable beneficial healthy gut flora, which is a prerequisite not only for boosting metabolic pathways and immune responses, but also for recovering good health conditions.Our work calls for a need to shift from chemotherapy to chemotherapy +lactobacillus treatment in patients suffering a cancer disease, and proposes a new probiotic formulation to be explored by pharmaceutical industry in prevention of health condition loss by alteration of the general immune system.